Fundraising Fox

DeepCure

Founded 2018 · 27 employees on LinkedIn · 6 known investors

Find your way into DeepCure

472 people in our graph share verified history with the DeepCure team — schools, employers, funds. One of them is your warm intro.

Noubar Afeyanunlockedknows Thrasyvoulos Karydis · together at MIT Center for Bits and Atoms (overlapped)
×6knows the team · via MIT Center for Bits and Atoms
×4knows the team · via MIT Media Lab
knows the team · via PathAI

DeepCure uses AI and machine learning to accelerate drug discovery and development for treating diseases. The company combines computational biology with experimental validation to identify and optimize therapeutic candidates.

AI & Machine LearningBiotechDigital HealthHealthtech

Founders & leadership

DeepCure was founded in 2018 by Kfir Schreiber, Thrasyvoulos Karydis, and Joseph Jacobson.

KSKfir Schreiber
Kfir SchreiberinCEO & Co-Founder
TKThrasyvoulos Karydis
Thrasyvoulos KarydisinCTO & Co-FounderHe holds an MSc in Biomathematics, Bioinformatics, and Computational Biology from MIT, and has prior experience in biotechnology with expertise in biophysics, computer science, and computational methods.
JJJoseph Jacobson
Joseph JacobsoninCo-Founder

Investors · 6

IAG Capital PartnersCharlestonvia Joel Whitley · inferred
The E14 FundCambridge · $1M – $5M
TLV PartnersTel Aviv · $3M – $70M

Also in the syndicate · 3

Benon Group Ltd.Morningside VenturesleadSapir Venture Partners

Funding

SEC filings, press & company announcements

$64M disclosed across 2 of 3 rounds · 2021–2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

DeepCure Raises $24.6 Million in Series A-1 Round | The SaaS Newsthesaasnews.com · Apr 2024DeepCure: Small Molecule Therapeutics Company Raises $24 Millionpulse2.com · Apr 2024DeepCure Closes $24M Series A-1 Fundingfinsmes.com · Apr 2024DeepCure Closes $24M Funding Round Led by IAG Capital Partnersbusinesswire.com · Apr 2024DeepCure Closes $40M Series A Funding Led by Morningside Venturesbusinesswire.com · Nov 2021AI drug discovery co DeepCure raises $40m - Globesen.globes.co.il · Nov 2021

Frequently asked questions

What does DeepCure do?
DeepCure uses AI and machine learning to accelerate drug discovery and development for treating diseases. The company combines computational biology with experimental validation to identify and optimize therapeutic candidates.
Who founded DeepCure?
DeepCure was founded by Kfir Schreiber, Thrasyvoulos Karydis, Joseph Jacobson in 2018.
Who are DeepCure's investors?
DeepCure's investors include IAG Capital Partners, The E14 Fund, TLV Partners.
How much funding has DeepCure raised?
DeepCure has disclosed $64M raised across 2 of its 3 known rounds.